Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of October 21)

The week's View summarizes the 10-year follow-up of the SYNTAX trial (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) and offers key points to remember from an article about lipid management for the prevention of atherosclerotic cardiovascular disease and a state-of-the-art review on the clinical and prognostic significance of soluble suppression of tumorigenesis-2 in heart failure.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Cardio-Oncology, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Atherosclerotic Disease (CAD/PAD), Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Homozygous Familial Hypercholesterolemia, Hypertriglyceridemia, Lipid Metabolism, Nonstatins, Novel Agents, Primary Hyperlipidemia, Statins, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Coronary Artery Disease, Exercise, Smoking

Keywords: EaglesEyeView, Angioplasty, Apolipoproteins B, Atherosclerosis, Biological Markers, Blood Glucose, Carcinogenesis, Cardiomyopathy, Dilated, Cholesterol, LDL, Coronary Artery Bypass, Coronary Artery Disease, Coronary Disease, C-Reactive Protein, Defibrillators, Diabetes Mellitus, Diabetes Mellitus, Type 2, Drug-Eluting Stents, Dyslipidemias, Eicosapentaenoic Acid, Exercise, Fatty Acids, Omega-3, Fish Oils, Heart Failure, Hemodynamics, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Hyperlipoproteinemia Type II, Hypolipidemic Agents, Hypertriglyceridemia, Immunosuppressive Agents, Inflammation, Length of Stay, Lipids, Myocardial Infarction, Natriuretic Peptides, Paclitaxel, Percutaneous Coronary Intervention, Plaque, Atherosclerotic, Primary Prevention, Proprotein Convertases, Quality of Life, Risk Factors, Risk Management, Secondary Prevention, Sirolimus, Smoking, Stents, Stroke, Thrombosis, Triglycerides, Troponin, Troponin T, Arrhythmias, Cardiac, Metabolic Syndrome X, Cardiac Surgical Procedures


< Back to Listings